Vol 6, No 5 (October 31, 2017) - Chinese Clinical Oncology

1. The series “Esophagus Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Geoffrey Y. Ku and David H. Ilson served as the unpaid Guest Editors for the series.

Vol 6, No 5 (October 31, 2017): Chinese Clinical Oncology (Esophagus Cancer-Guest Editors: Geoffrey Y. Ku, David H. Ilson)

Preface on Esophagus Cancer¹

Preface on Esophagus Cancer

Review Article on Esophagus Cancer¹

Radiation techniques for esophageal cancer

The management of localized esophageal squamous cell carcinoma: Western approach

Surgical management of esophageal cancer

Systemic therapy for esophagogastric cancer: targeted therapies

Systemic therapy for esophageal cancer: chemotherapy

Screening and prevention strategies and endoscopic management of early esophageal cancer

Issues in the management of esophageal cancer and geriatric patients

Adenocarcinoma of the esophagus: controversies and consensus

Systemic therapy for esophagogastric cancer: immune checkpoint inhibition

Review Article

Rational combination of immunotherapy for triple negative breast cancer treatment

Editorial

Trastuzumab biosimilar in early breast cancer setting: will there be direct patient benefits?

Meet the Professor²

ERAS & Tubeless—Michael Haddock: the past and future of proton beam

2. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.